Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-26

FDA Approved: BUMETANIDE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)

View source ↗

Summary

FDA approved Glenmark Pharmaceuticals USA's Original Application for bumetanide, authorizing the generic diuretic bumetanide for U.S. use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)

Snippet

ORIG AP for BUMETANIDE (BUMETANIDE)